Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Dazoxiben |
EINECS | N/A |
CAS No. | 78218-09-4 | Density | 1.25 g/cm3 |
PSA | 64.35000 | LogP | 1.66030 |
Solubility | N/A | Melting Point |
230-235 ºC |
Formula | C12H12 N2 O3 | Boiling Point | 491.2 °C at 760 mmHg |
Molecular Weight | 232.239 | Flash Point | 250.9 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | R22; R41 | |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
4-[2-(1H-Imidazol-1-yl)ethoxy]benzoicacid;Dazoxiben;Dazoxiben [INN:BAN];Dazoxiben [INN-Spanish];Dazoxibene [INN-French];Dazoxibenum;Dazoxibenum [INN-Latin];UK 37248;UNII-09ZFC7974Q;p-(2-Imidazol-1-ylethoxy)benzoic acid; |
Article Data | 2 |
IUPAC Name: 4-(2-Imidazol-1-ylethoxy)benzoic acid
Synonyms of Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]- (CAS NO.78218-09-4): Dazoxiben [INN:BAN] ; 4-(2-(1-Imidazolyl)ethoxy)benzoesaeure ; Dazoxiben ; Dazoxiben [INN-Spanish] ; Dazoxibene ; Dazoxibene [INN-French] ; Dazoxibenum ; Dazoxibenum [INN-Latin] ; UK 37248 ; UNII-09ZFC7974Q ; p-(2-Imidazol-1-ylethoxy)benzoic acid
CAS NO: 78218-09-4
Classification Code: Enzyme inhibitors
Molecular Formula of Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]- (CAS NO.78218-09-4): C12H12N2O3
Molecular Weight: 232.2353
Molecular Structure:
Melting Point: 230-235°C
Polar Surface Area: 53.35 Å2
Index of Refraction: 1.593
Molar Refractivity: 62.85 cm3
Molar Volume: 185.3 cm3
Surface Tension: 49.8 dyne/cm
Density of Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]- (CAS NO.78218-09-4): 1.25 g/cm3
Flash Point: 250.9 °C
Enthalpy of Vaporization: 79.82 kJ/mol
Boiling Point: 491.2 °C at 760 mmHg
Vapour Pressure: 1.83E-10 mmHg at 25°C
Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]- (CAS NO.78218-09-4) is used as selective TVA2 (thrombus A2) synthase inhibitor, selective thromboxane A2 synthetase inhibitor. Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]- (CAS NO.78218-09-4) is used for the treatment of angina, and try to thromboembolic diseases such as myocardial infarction, and Raynaud's disease treatment.